Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 5 | Colburn Richard Edward IIIChief Product & Tech Officer | Grant or award | A | — 86.6K sh | Mar 18, 2026 |
| 5 | Ganesan SatishSee Remarks | Tax withholding | F | $11K 147 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 4 | Cowan ElviaSVP, Finance & CAO | Open-market sale · 10b5-1 plan | SELL | $82K 1,487 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 4 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Open-market sale · 10b5-1 plan | SELL | $108K 7,767 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 4 | Farnum RhondaSVP, COMM & MEDICAL AFFAIRS | Open-market sale · 10b5-1 plan | SELL | $108K 7,766 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 3 | Rishel JeremyChief Technology Officer | Option exercise · 10b5-1 plan | M | — 271.8K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 3 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 19.5K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 3 | Wu LeiDirector, Chief Executive Officer, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $21K 490 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 1 | Fruge Mary CelesteVP, General Counsel | Open-market sale · 10b5-1 plan | SELL | $14K 1,000 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 1 | Sumner CrystalSee Remarks | Open-market sale · 10b5-1 plan | SELL | $20K 5,055 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 1 | Cowan ElviaSVP, Finance & CAO | Open-market sale · 10b5-1 plan | SELL | $23K 405 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 1 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | $580K 40.0K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | $107K 10.0K sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Tax withholding · 10b5-1 plan | F | $14K 91 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Fruge Mary CelesteVP, General Counsel | Option exercise · 10b5-1 plan | M | — 1,000 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Doyle MittieChief Medical Officer | Option exercise · 10b5-1 plan | M | — 5,992 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Fruge Mary CelesteVP, General Counsel | Option exercise · 10b5-1 plan | M | $4,320 1,000 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 310 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Tax withholding · 10b5-1 plan | F | $14K 87 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 40.0K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $280K 1,567 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 9,204 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Grant or award · 10b5-1 plan | A | — 893 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Option exercise · 10b5-1 plan | M | — 295 sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kimball JenniferChief Accounting Officer | Grant or award · 10b5-1 plan | A | — 2,679 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Rishel JeremyChief Technology Officer | Option exercise · 10b5-1 plan | M | — 28.7K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Rishel JeremyChief Technology Officer | Option exercise · 10b5-1 plan | M | — 28.7K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | $98K 9,204 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Hohenstein KenChief Revenue Officer | Option exercise · 10b5-1 plan | M | — 10.0K sh | Mar 18, 2026 traded Mar 17, 2026 |
| 0 | Kleinerman ChristianEVP, Product Management | Tax withholding · 10b5-1 plan | F | $260K 1,456 sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Sumner CrystalSee Remarks | Grant or award · 10b5-1 plan | A | — 297.3K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 0 | Sumner CrystalSee Remarks | Grant or award · 10b5-1 plan | A | — 693.8K sh | Mar 18, 2026 traded Mar 16, 2026 |
| 44 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Mar 17, 2026 traded Mar 12, 2026 |
| 44 | Deslarzes Jean-ChristopheDirector | Open-market purchase | BUY | $41K 1,665 sh | Mar 17, 2026 traded Mar 2, 2026 |
| 44 | Cleo FieldsDSelf | Purchase | BUY | $1,001 – $15K | Mar 17, 2026 traded Mar 12, 2026 |
| 39 | Valentine CurtisChief Financial Officer | Open-market sale | SELL | $183K 2,268 sh | Mar 17, 2026 traded Mar 16, 2026 |
| 33 | Fazel PayvandSenior Vice President | Open-market sale | SELL | $212K 2,898 sh | Mar 17, 2026 traded Mar 13, 2026 |
| 31 | Rovinsky ZacharyChief Financial Officer | Grant or award | A | — 25.0K sh | Mar 17, 2026 traded Feb 17, 2026 |
| 30 | Reuter James ADirector, President and CEO | Grant or award | A | $1.04M 31.4K sh | Mar 17, 2026 traded Mar 15, 2026 |
| 30 | Thomas R. SuozziDSelf | Sale | SELL | $1,001 – $15K | Mar 17, 2026 traded Feb 18, 2026 |